Background The multistep molecular model of breast carcinogenesis is based on the oestrogen receptor(ER) status of the tumour. Its two main arms comprise ER-positive and ER-negative breast carcinomas(BCa), which are associated with Nottingham grade(NG) of the tumour and different proliferative epithelial changes. According to the model, columnar cell lesions(CCL), lobular carcinoma in-situ(LCIS) and atypical ductal hyperplasia(ADH), low-grade ductal carcinoma in-situ (LG-DCIS) are associated with low grade ER-positive tumours and microglandular adenosis (MGA), pleomorphic LCIS(PLCIS), high-grade DCIS(HG-DCIS) are associated with ER-negative high grade tumours. This study aims to describe the association between proliferative epithelial changes in breast tissue adjacent to tumour, in relation to the ER status and NG of the tumour. Methods This descriptive cross-sectional study included 420, wide local excision and mastectomy specimens of BCa from National Hospital of Sri Lanka, between 2017–2019. The histopathological features of the tumour and proliferative epithelial changes in tumour adjacent tissue within 10 mm distance from the tumour-host interface were evaluated independently by two pathologists. The ER, PR(Progesterone receptor) and HER2 status assessed by immunohistochemistry(IHC) was reviewed. The associations between above epithelial lesions and ER status and NG{categorised as low grade (NG1 and NG2) and high grade (NG3)} of the tumour were analyzed. Results ER positive BCa showed significant associations with CCH (p = 0.04), FEA (p = 0.035) and LGDCIS (p < 0.001). Although PLCIS was more frequent in ER positive tumours, the association did not attain statistical significance. ER negative BCa showed a significant association with HGDCIS (p = 0.016). CCLs as a whole (p = 0.005) and also CCC (p = 0.006) and FEA (p = 0.048) and LGDCIS (p < 0.001) showed significant associations with low NG tumours. High NG tumours showed a significant association with HGDCIS (p < 0.001). Microglandular adenosis was not identified in our study population. Conclusion These morphological findings support the multistep molecular based pathogenetic pathways of breast carcinoma in the studied setting in South Asia. Identification of these proliferative epithelial components in a core biopsy that is negative for BCa, should prompt for close clinicoradiological correlation, and if necessary re-biopsy of women suspected of harbouring a BCa.
With the control of communicable diseases by improved health care facilities, non communicable diseases (NCD) have surpassed communicable diseases in morbidity and mortality in Sri Lanka. Among these, cardiovascular diseases have the highest mortality with respiratory diseases, trauma, poisoning, diabetes, kidney, liver diseases followed by cancers showing an upward trend. Although there is an increase in incidence of cancer from 1990 to 2007, cancer related deaths remain static due to early detection and better treatment modalities provided by health care services. However, malignancies had the highest mortality in 2009 followed by deaths related to cardiovascular causes. Cancer is a major component of the non communicable disease burden in Sri Lanka with an increase in incidence of 31.6 in 1995 to 71.6 in 2007 per 100,000 population. Cancer detection and management constitute a major component of the health care system in Sri Lanka. Therefore pathologists play a crucial role in diagnosis of malignancy. Among the Sri Lankan males, the common sites of malignancy are lip, oral cavity and pharynx, trachea, bronchus, lung and oesophagus, followed by colorectum, lymphoma, leukemia, larynx, prostate and stomach; commonest three cancer sites among females are breast, cervix uteri and thyroid followed by oesophagus, ovary, colorectum, lip, oral cavity, pharynx, leukemia, uterus and lymphoma. The five most common malignancies without gender consideration are breast, lip and oral cavity, pharynx, cervix uteri and oesophagus. Leukaemias, lymphomas and brain tumours are the common malignancies among children (Source: National Cancer Control Programme data).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations –citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.